Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?

Intravesical onabotulinumtoxinA (BoNT-A) injections have been proposed to treat both overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS) in patients with refractory conditions. We compared adverse events (AEs) after BoNT-A treatment between IC/BPS and OAB in women. IC/B...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Yuh-Chen, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810220/
https://www.ncbi.nlm.nih.gov/pubmed/26999201
http://dx.doi.org/10.3390/toxins8030075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810220/
https://www.ncbi.nlm.nih.gov/pubmed/26999201
http://dx.doi.org/10.3390/toxins8030075

Ejemplares similares